This inventor holds 5 USPTO granted patents. Top assignee: Bahçesehir Üniversitesi. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Seyma Calis: Innovator in Therapeutic Compounds
Introduction
Seyma Calis is a prominent inventor based in Besiktas, Istanbul, Turkey. He has made significant contributions to the field of therapeutic compounds, holding a total of five patents. His work focuses on the development of novel small therapeutic compounds that serve as inhibitors for critical biological targets.
Latest Patents
One of Seyma Calis's latest patents involves the physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor. This invention relates to a compound represented by a specific formula, or a pharmaceutically acceptable derivative thereof, aimed at providing a new approach to inhibit BCL-2, a protein that plays a crucial role in regulating cell death.
Career Highlights
Seyma Calis is affiliated with Bahcesehir Universitesi, where he continues to advance his research and innovation in the field of therapeutic compounds. His academic and professional journey reflects a commitment to scientific excellence and innovation.
Collaborations
Seyma has collaborated with notable colleagues, including Muge Didem Orhan and Berna Dogan, who contribute to his research endeavors. These collaborations enhance the scope and impact of his work in the scientific community.
Conclusion
Seyma Calis stands out as an influential inventor in the realm of therapeutic compounds, with a focus on BCL-2 inhibitors. His contributions are paving the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile